Literature DB >> 8244465

Suppression of murine IgM, IgG, IgA and IgE antibody responses by alveolar macrophages.

M G Steele1, H B Herscowitz.   

Abstract

Freshly recovered pulmonary alveolar macrophages (AM) and the AM-derived established cell line, MH-S, have previously been shown to be highly suppressive of in vitro IgM anti-sheep erythrocyte (SRBC) responses. Supernatants obtained from cultures of AM incubated with antigen-stimulated lymphocytes or from the MH-S cell line alone have also been shown to be suppressive when added to the in vitro antibody-forming system. In order to determine if AM and MH-S cells, owing to their mucosal location, could differentially regulate antibody responses including immunoglobulin isotypes other than IgM, an in vitro system for the detection of cells producing IgG, IgA and IgE anti-2,4 dinitrophenol (DNP) antibody was developed. These studies demonstrate that AM, MH-S cells, and MH-S culture supernatants suppress the in vitro generation of IgM, IgG, IgA and IgE anti-DNP spot-forming cells (SFC). No apparent differential regulation of any of the four murine IgG anti-DNP antibody subclasses was observed. Time-course experiments suggested that optimal AM- and MH-S-mediated suppression occurred 18 hr after culture initiation. Both AM and MH-S cells suppressed IgM and IgG anti-DNP antibody responses in a dose-related manner, suggesting that MH-S is a good model for the study of AM-mediated immunoregulation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8244465      PMCID: PMC1422121     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  Characterization of immune inducer and suppressor macrophages from the normal human lung.

Authors:  M A Spiteri; L W Poulter
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

Review 2.  Macrophages and polymorphonuclear neutrophils in lung defense and injury.

Authors:  Y Sibille; H Y Reynolds
Journal:  Am Rev Respir Dis       Date:  1990-02

3.  Macrophage-lymphocyte interactions mediated by soluble factors.

Authors:  H B Herscowitz; K J Pennline; R E Conrad; S E Ullrich; H R Gerber
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

4.  A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells.

Authors:  J D Sedgwick; P G Holt
Journal:  J Immunol Methods       Date:  1983-02-25       Impact factor: 2.303

5.  A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells.

Authors:  C C Czerkinsky; L A Nilsson; H Nygren; O Ouchterlony; A Tarkowski
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

6.  Methods for the collection of peritoneal and alveolar macrophages.

Authors:  R M McCarron; D K Goroff; J E Luhr; M A Murphy; H B Herscowitz
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

Review 7.  Lymphokine control of in vivo immunoglobulin isotype selection.

Authors:  F D Finkelman; J Holmes; I M Katona; J F Urban; M P Beckmann; L S Park; K A Schooley; R L Coffman; T R Mosmann; W E Paul
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

8.  Molecular basis of "suppressor" macrophages. Arginine metabolism via the nitric oxide synthetase pathway.

Authors:  C D Mills
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

9.  Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway.

Authors:  J E Albina; J A Abate; W L Henry
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

10.  Antigen-presenting function of alveolar macrophages: uptake and presentation of Listeria monocytogenes.

Authors:  D S Weinberg; E R Unanue
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

View more
  3 in total

1.  A critical role for alveolar macrophages in elicitation of pulmonary immune fibrosis.

Authors:  J Zhang-Hoover; A Sutton; N van Rooijen; J Stein-Streilein
Journal:  Immunology       Date:  2000-12       Impact factor: 7.397

2.  Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production.

Authors:  Mairi C Noverr; Gary M Cox; John R Perfect; Gary B Huffnagle
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

Review 3.  Characteristics of suppressor macrophages induced by mycobacterial and protozoal infections in relation to alternatively activated M2 macrophages.

Authors:  Haruaki Tomioka; Yutaka Tatano; Win Win Maw; Chiaki Sano; Yuichi Kanehiro; Toshiaki Shimizu
Journal:  Clin Dev Immunol       Date:  2012-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.